Verificando…
Traducido automáticamente. Dosis y advertencias: consulta el original en inglés. Leer en inglés
Inicio / Registrado en Nigeria / Ceremit-150 Capsule

Ceremit-150 Capsule

NAFDAC Reg. No. A4-7654 Estupefaciente

Registrado en NAFDAC. Registro activoAs of 6 November 2026 · synced automatically from official sources.
Producto
Ceremit-150 Capsule
Número NAFDAC
A4-7654
Principio activo
Clindamycin (Clindamycin Hydrochloride)
Dosis
150 mg
Forma
Capsule
Tamaño del envase
1 x 10's (in PVC-Alu blister)
Fabricante
No Constan
Solicitante (titular)
Dony-Triumph and Company Nigeria Limited
Approved
28 Oct 2021
Estado
Inactive Ver en NAFDAC ↗
Registro válido hasta
27 Oct 2026
Alertas de la OMS
No se ha encontrado ninguno
Informes de la comunidad
Ninguno
Tiempos comprobados
0

Pero sobre el medicamento, Clindamycin: uses, dosage and brands worldwide

Lo que encontramos

  • Ceremit-150 Capsule is on the NAFDAC register with an active registration (A4-7654). A valid number alone does not prove a pack is genuine — counterfeiters copy real numbers, so also check the expiry date, seal and print quality.

Generado automáticamente a partir del registro NAFDAC, QUIÉN alerta y los datos de la comunidad a partir de hoy. Este no es un consejo médico. Siga siempre a su médico o farmacéutico.

How to use Ceremit-150 Capsule

Lo que dice el prospecto oficial. Si te lo recetó un médico, sigue la receta. Si el prospecto de tu caja es distinto, manda el de tu caja.

Para quién es

CLINICAL STUDIES In one 12-week multicenter, randomized, evaluator-blind, vehicle-controlled, parallel comparison clinical trial in which patients used CLINDAGEL (clindamycin phosphate topical gel, 1%) once daily or the vehicle gel once daily, in the treatment of acne vulgaris of mild to moderate severity, CLINDAGEL applied once daily was more effective than the vehicle applied once daily. The mean percent reductions in lesion counts at the end of treatment in this study are shown in the following table: Lesions CLINDAGEL QD N=162 Vehicle Gel QD N=82 Inflammatory 51% 40% P

Cómo tomarlo y con qué frecuencia
  • Apply a thin film of CLINDAGEL once daily to the skin where acne lesions appear
  • Use enough to cover the entire affected area lightly
  • Keep container tightly closed
Talk to a doctor first if

CLINDAGEL is contraindicated in individuals with a history of hypersensitivity to preparations containing clindamycin or lincomycin, a history of regional enteritis or ulcerative colitis, or a history of antibiotic-associated colitis.

Warnings

Orally and parenterally administered clindamycin has been associated with severe colitis, which may result in patient death. Use of the topical formulation of clindamycin results in absorption of the antibiotic from the skin surface. Diarrhea, bloody diarrhea, and colitis (including pseudomembranous colitis) have been reported with the use of topical and systemic clindamycin. Studies indicate a toxin(s) produced by Clostridia is one primary cause of antibiotic-associated colitis. The colitis is usually characterized by severe persistent diarrhea and severe abdominal cramps and may be associated with the passage of blood and mucus. Endoscopic examination may reveal pseudomembranous colitis. …

Posibles efectos secundarios

In the one well-controlled clinical study comparing CLINDAGEL and its vehicle, the incidence of skin and appendages adverse events occurring in ≥1% of the patients in either group is presented in the following table: Number (%) of Patients Body System/Adverse Event CLINDAGEL QD N=168 Vehicle Gel QD N=84 Skin and Appendages Disorders Dermatitis 0 (0.0) 1 (1.2) Dermatitis contact 0 (0.0) 1 (1.2) Dermatitis fungal 0 (0.0) 1 (1.2) Folliculitis 0 (0.0) 1 (1.2) Photosensitivity reaction 0 (0.0) 1 (1.2) Pruritus 1 (0.6) 1 (1.2) Rash erythematous 0 (0.0) 0 (0.0) Skin dry 0 (0.0) 0 (0.0) Peeling 1 (0.6) 0 (0.0) Orally and parenterally administered clindamycin has been associated with severe colitis, …

If you take too much

Topically applied CLINDAGEL may be absorbed in sufficient amounts to produce systemic effects (see WARNINGS ).

Si olvidas una dosis

Tómala en cuanto te acuerdes, salvo que falte poco para la siguiente. En ese caso, sáltate la olvidada. Nunca tomes dos dosis a la vez para compensar. Revisa tu prospecto, porque algunos medicamentos son distintos.

From the official U.S. FDA label for this active ingredient. Your pack may have a different strength, so always read its leaflet. If a doctor prescribed it, follow the prescription. Ask a pharmacist if you are unsure. Label dated 2020-01-01.

Label for clindamycin (clindamycin hydrochloride), the active ingredient registered with NAFDAC.

Check your pack of Ceremit-150 Capsule

Add the expiry date on your pack for a full Trust Score.

O haz fotos de la caja
Te quedan 3 verificaciones gratis hoy Official sources: U.S. FDA · EMA (EU) · Health Canada · WHO alerts

About Ceremit-150 Capsule

What is in Ceremit-150 Capsule?

Ceremit-150 Capsule contains Clindamycin (Clindamycin Hydrochloride) (150 mg), as capsule, according to its NAFDAC registration record.

Is Ceremit-150 Capsule registered with NAFDAC?

Yes. Ceremit-150 Capsule is listed on the NAFDAC register under registration number A4-7654, and its registration is active as of 6 November 2026.

Has Ceremit-150 Capsule been flagged as fake or recalled?

No WHO falsified or substandard medical product alert currently matches Ceremit-150 Capsule in our automatically synced alert list.

How can I check that my pack of Ceremit-150 Capsule is genuine?

Run a free authenticity scan with the NAFDAC number A4-7654, your pack's expiry date and batch number to get a Trust Score, compare the pack with the NAFDAC record (ingredient, strength, form, manufacturer), and buy only from licensed pharmacies.

How do I take Ceremit-150 Capsule?

Follow your prescription or the leaflet in your pack. The official label says: Apply a thin film of CLINDAGEL once daily to the skin where acne lesions appear. Use enough to cover the entire affected area lightly. Keep container tightly closed.…

What is Ceremit-150 Capsule used for?

CLINICAL STUDIES In one 12-week multicenter, randomized, evaluator-blind, vehicle-controlled, parallel comparison clinical trial in which patients used CLINDAGEL (clindamycin phosphate topical gel, 1%) once daily or the vehicle gel once daily, in the treatment of acne vulgaris of mild to moderate severity, CLINDAGEL applied once daily was more effective than the vehicle applied once daily. The mea (Summarised from the official U.S. FDA label for clindamycin (clindamycin hydrochloride). Always follow your doctor or pharmacist.)

Patient reviews

–No reviews yet
5★
0
4★
0
3★
0
2★
0
1★
0
Have you used Ceremit-150 Capsule? Share your experience to help other patients. Sign in to review

Reviews are personal experiences from PillVera users, not medical advice. Report side effects to your doctor and to NAFDAC.